Sagona Antonia P, Grigonyte Aurelija M, MacDonald Paul R, Jaramillo Alfonso
Warwick Integrative Synthetic Biology Centre and School of Life Sciences, University of Warwick, Coventry, CV4 7AL, UK.
Integr Biol (Camb). 2016 Apr 18;8(4):465-74. doi: 10.1039/c5ib00267b. Epub 2016 Feb 24.
Phages or bacteriophages, viruses that infect and replicate inside bacteria, are the most abundant microorganisms on earth. The realization that antibiotic resistance poses a substantial risk to the world's health and global economy is revitalizing phage therapy as a potential solution. The increasing ease by which phage genomes can be modified, owing to the influx of new technologies, has led to an expansion of their natural capabilities, and a reduced dependence on phage isolation from environmental sources. This review will discuss the way synthetic biology has accelerated the construction of genetically modified phages and will describe the wide range of their applications. It will further provide insight into the societal and economic benefits that derive from the use of recombinant phages in various sectors, from health to biodetection, biocontrol and the food industry.
噬菌体,即感染细菌并在细菌内复制的病毒,是地球上数量最多的微生物。抗生素耐药性对全球健康和全球经济构成重大风险,这一认识正在使噬菌体疗法作为一种潜在解决方案得以复兴。由于新技术的涌入,噬菌体基因组的修饰变得越来越容易,这导致了它们天然能力的扩展,以及对从环境来源分离噬菌体的依赖性降低。本综述将讨论合成生物学加速基因工程噬菌体构建的方式,并将描述其广泛的应用。它还将进一步深入探讨在从健康到生物检测、生物防治和食品工业等各个领域使用重组噬菌体所带来的社会和经济效益。